Poly-L-Histidine-Coated Nanoparticles for Targeted Doxorubicin Delivery
In the ever-evolving landscape of drug delivery systems, recent advancements have manifested in the innovative fabrication of poly-L-histidine-coated mesoporous silica ...
Tag: systemic toxicity reduction
Groundbreaking Cancer Therapy Advances to Phase 2 Trials
A groundbreaking development in cancer therapeutics has emerged from the collaborative efforts of Georgia State University researchers and the biotech ...
Novel ADC Targets Fucosyl-GM1 in Lung Cancer
In an exciting development in the realm of cancer therapeutics, researchers have unveiled a novel antibody-drug conjugate (ADC) known as ...
Real-World Outcomes of Nab-Paclitaxel in Advanced Breast Cancer
In the evolving landscape of cancer treatment, the efficacy of therapies in real-world settings often garners considerable attention. A pivotal ...
HER3-Targeted Antibody-Drug Conjugate Demonstrates Potential Against Treatment-Resistant Solid Tumors
A groundbreaking advancement in cancer therapeutics is emerging from a recent international clinical trial investigating the novel targeted therapy, DB-1310. ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!